Penumbra, Inc. to Present at the J.P. Morgan 42nd Annual Healthcare Conference
Werte in diesem Artikel
ALAMEDA, Calif., Dec. 18, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the J.P. Morgan 42nd Annual Healthcare Conference on Monday, January 8, 2024.
Event: J.P. Morgan 42nd Annual Healthcare Conference
Date: Monday, January 8, 2024
Time: 11:15am ET/8:15am PT
A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.
Investor Relations
Penumbra, Inc.
510-995-2461
investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-jp-morgan-42nd-annual-healthcare-conference-302018382.html
SOURCE Penumbra, Inc.
Ausgewählte Hebelprodukte auf Penumbra
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Penumbra
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Penumbra Aktie News
Penumbra Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Penumbra nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.12.17 | Penumbra Market Perform | BMO Capital Markets | |
| 24.10.16 | Penumbra Outperform | BMO Capital Markets | |
| 30.11.15 | Penumbra Buy | Canaccord Adams |
